297 related articles for article (PubMed ID: 10811911)
1. High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer.
Ferguson AT; Evron E; Umbricht CB; Pandita TK; Chan TA; Hermeking H; Marks JR; Lambers AR; Futreal PA; Stampfer MR; Sukumar S
Proc Natl Acad Sci U S A; 2000 May; 97(11):6049-54. PubMed ID: 10811911
[TBL] [Abstract][Full Text] [Related]
2. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
3. Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma.
Iwata N; Yamamoto H; Sasaki S; Itoh F; Suzuki H; Kikuchi T; Kaneto H; Iku S; Ozeki I; Karino Y; Satoh T; Toyota J; Satoh M; Endo T; Imai K
Oncogene; 2000 Nov; 19(46):5298-302. PubMed ID: 11077447
[TBL] [Abstract][Full Text] [Related]
4. Aberrant methylation profile of 14-3-3 sigma and its reduced transcription/expression levels in Chinese sporadic female breast carcinogenesis.
Luo J; Feng J; Lu J; Wang Y; Tang X; Xie F; Li W
Med Oncol; 2010 Sep; 27(3):791-7. PubMed ID: 19685192
[TBL] [Abstract][Full Text] [Related]
5. HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells.
Krop IE; Sgroi D; Porter DA; Lunetta KL; LeVangie R; Seth P; Kaelin CM; Rhei E; Bosenberg M; Schnitt S; Marks JR; Pagon Z; Belina D; Razumovic J; Polyak K
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9796-801. PubMed ID: 11481438
[TBL] [Abstract][Full Text] [Related]
6. 5' CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer.
Zöchbauer-Müller S; Fong KM; Maitra A; Lam S; Geradts J; Ashfaq R; Virmani AK; Milchgrub S; Gazdar AF; Minna JD
Cancer Res; 2001 May; 61(9):3581-5. PubMed ID: 11325823
[TBL] [Abstract][Full Text] [Related]
7. Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer.
Umbricht CB; Evron E; Gabrielson E; Ferguson A; Marks J; Sukumar S
Oncogene; 2001 Jun; 20(26):3348-53. PubMed ID: 11423985
[TBL] [Abstract][Full Text] [Related]
8. Expression of the Hypermethylated in Cancer gene (HIC-1) is associated with good outcome in human breast cancer.
Nicoll G; Crichton DN; McDowell HE; Kernohan N; Hupp TR; Thompson AM
Br J Cancer; 2001 Dec; 85(12):1878-82. PubMed ID: 11747329
[TBL] [Abstract][Full Text] [Related]
9. CHFR-associated early G2/M checkpoint defects in breast cancer cells.
Erson AE; Petty EM
Mol Carcinog; 2004 Jan; 39(1):26-33. PubMed ID: 14694445
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells.
Kim TY; Jong HS; Song SH; Dimtchev A; Jeong SJ; Lee JW; Kim TY; Kim NK; Jung M; Bang YJ
Oncogene; 2003 Jun; 22(25):3943-51. PubMed ID: 12813468
[TBL] [Abstract][Full Text] [Related]
11. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
[TBL] [Abstract][Full Text] [Related]
12. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J
Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of the 14-3-3 sigma gene is associated with 5' CpG island hypermethylation in human cancers.
Suzuki H; Itoh F; Toyota M; Kikuchi T; Kakiuchi H; Imai K
Cancer Res; 2000 Aug; 60(16):4353-7. PubMed ID: 10969776
[TBL] [Abstract][Full Text] [Related]
14. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
Pulukuri SM; Rao JS
Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
[TBL] [Abstract][Full Text] [Related]
15. Characterization of {gamma}-aminobutyric acid type A receptor-associated protein, a novel tumor suppressor, showing reduced expression in breast cancer.
Klebig C; Seitz S; Arnold W; Deutschmann N; Pacyna-Gengelbach M; Scherneck S; Petersen I
Cancer Res; 2005 Jan; 65(2):394-400. PubMed ID: 15695379
[TBL] [Abstract][Full Text] [Related]
16. Methylation and gene silencing of the Ras-related GTPase gene in lung and breast cancers.
Suzuki M; Shigematsu H; Shames DS; Sunaga N; Takahashi T; Shivapurkar N; Iizasa T; Minna JD; Fujisawa T; Gazdar AF
Ann Surg Oncol; 2007 Apr; 14(4):1397-404. PubMed ID: 17195088
[TBL] [Abstract][Full Text] [Related]
17. Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas.
Zhong S; Tang MW; Yeo W; Liu C; Lo YM; Johnson PJ
Clin Cancer Res; 2002 Apr; 8(4):1087-92. PubMed ID: 11948118
[TBL] [Abstract][Full Text] [Related]
18. The cell cycle checkpoint gene Rad9 is a novel oncogene activated by 11q13 amplification and DNA methylation in breast cancer.
Cheng CK; Chow LW; Loo WT; Chan TK; Chan V
Cancer Res; 2005 Oct; 65(19):8646-54. PubMed ID: 16204032
[TBL] [Abstract][Full Text] [Related]
19. Two-hit inactivation of FHIT by loss of heterozygosity and hypermethylation in breast cancer.
Yang Q; Nakamura M; Nakamura Y; Yoshimura G; Suzuma T; Umemura T; Shimizu Y; Mori I; Sakurai T; Kakudo K
Clin Cancer Res; 2002 Sep; 8(9):2890-3. PubMed ID: 12231533
[TBL] [Abstract][Full Text] [Related]
20. Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells.
Tuck AB; Arsenault DM; O'Malley FP; Hota C; Ling MC; Wilson SM; Chambers AF
Oncogene; 1999 Jul; 18(29):4237-46. PubMed ID: 10435636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
